The Wall Street Journal

January 6, 2005

TRACKING THE NUMBERS
DOW JONES REPRINTS
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit:
www.djreprints.com.

• See a sample reprint in PDF format.
• Order a reprint of this article now.


Outside Audit
Baxter's Hedge in 2002
Turned Into Costly Bet

Four-Year Lock of Dollar
Against Euro Means Loss
Of a Currency Kick to Profit

By HENNY SENDER
Staff Reporter of THE WALL STREET JOURNAL
January 6, 2005; Page C3

Sometimes what starts out as a hedge ends up looking like an outright bet -- and a wild one at that.

Just ask analysts following Baxter International Inc., who are wondering why the Deerfield, Ill., medical-products company in 2002 opted for a hedge that locked in the dollar's movement against the euro -- for four years. That is a staggeringly long term by the standards of most currency hedges, particularly in a world where global fortunes, and therefore exchange rates, can change in a matter of months or weeks. Most companies hedge out currency exposure for a period of six or 12 months.

The hedge, effectively a bet that the dollar would continue to rise against the European currency, is costing Baxter and its shareholders plenty. But the company's current management "is not responsible for these problems," says Glenn Reicin, who covers the company for Morgan Stanley. Former Baxter Chairman and Chief Executive Officer Harry M. Kraemer Jr. resigned last year amid discontent about the company's financial performance and share price and was succeeded in April by current CEO Robert L. Parkinson Jr.

Specifically, Baxter aimed to fix the exchange rate for products it made in the U.S. and sold in Europe. So in 2002 it entered into a type of hedge that guaranteed every euro of goods it sold would be valued at 95 cents against the euro.

Today, one euro fetches $1.3260, nearly 40% above the rate Baxter locked in. Normally, a declining dollar boosts a U.S. firm's revenue when foreign-currency sales are translated back into the home currency. But by locking in that 95-cent rate, Baxter lost the currency kick to its earnings.

"We view these hedges as more of a bet on the direction of the dollar -- and one that turned out to be wrong," Morgan Stanley analysts wrote in a recent report. "We project that these hedges have significantly cost the company in potential earnings upside."

Indeed, Baxter's hedging headache comes at a time when many U.S. companies have been the beneficiaries of the dollar's decline as their goods become cheaper abroad. The top 25 U.S. companies made 43% of their revenue abroad, with international sales up 15% from the previous year, according to Morgan Stanley, with most of these gains because of the dollar's move.

The matter also shows how the derivatives that are the tools of many hedging programs can be a mix of blessing and curse: Used wisely, these products, which derive their value from an underlying asset, can minimize volatility and protect gains. But poorly executed or used over a long period of time, they also can amplify the very losses they are designed to minimize.

Baxter's plight goes beyond the currency hedges. Baxter also entered into another type of transaction that it refers to as net-investment hedges to protect the value of its European assets, including its European facilities and inventory, according to a Baxter spokeswoman. These hedges were in the form of so-called cross-currency swaps that fix the exchange rate between dollars and euros. The spokeswoman says these swaps originally were slated to be in place until 2009, although the company is now unwinding some of these -- albeit at a cost.

[Currency]

By the end of the company's third quarter on Sept. 30, the total market value of the losses on what the company refers to as the "net investment hedge portfolio" amounted to $956 million, according to a presentation by Chief Financial Officer John Greisch on an Oct. 21 conference call.

Because the company has decided to "reduce the level of financial risk associated with these hedges," Mr. Greisch added on that call, Baxter was in the process of entering into offsetting hedges.

That means, he said, that half the losses, or $478 million, will be locked in. By the end of the third quarter the company had locked in about 30% of the loss, or $296 million. Baxter planned to lock in the remainder of that $478 million in the fourth quarter just ended.

The company expects the cost of entering into such offsetting hedges will amount to some $338 million in 2005 and will reduce cash flow by that amount, the spokeswoman says.

Meanwhile, the Morgan Stanley analysts calculate that the first type of hedges will have cost the company 37 cents a share over their four-year life.

The Baxter spokeswoman declined to comment on the per-share cost to the company of its hedges. In 2003, Baxter had net income of $866 million, or $1.43 a share, on sales of $8.9 billion.

An irony for Baxter is that when its hedges finally lapse, its financial performance will look better compared with the previous year.

"This ultimately reverses when the contracts expire and helps support our view that [earnings-per-share] growth in 2006 will be significant," Morgan Stanley analysts wrote in a December report.

That leaves the remainder of the cross-currency swaps. "They will be settled as they mature or possibly sooner, depending on the level of our cash flow," the Baxter spokeswoman says. "There will be additional costs."

Write to Henny Sender at henny.sender@wsj.com1

URL for this article:
http://online.wsj.com/article/0,,SB110496717302418102,00.html

Hyperlinks in this Article:
(1) mailto:henny.sender@wsj.com
Copyright 2005 Dow Jones & Company, Inc. All Rights Reserved
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.